Literature DB >> 1737832

Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia.

S Karpatkin1, M Nardi.   

Abstract

Autoimmune antiidiotype-like antibody (Ab2) directed against anti-HIV-1gp120 (Ab1) was found in high titer in the sera of 10 consecutive homosexual and 11 narcotic addict HIV-1-related immunologic thrombocytopenia (HIV-1-ITP) patients, was barely detectable in 10 nonthrombocytopenic HIV-1 sero-positive individuals, and was not detectable in 5 normal subjects by use of a solid-phase RIA. Reactivity of autologous Ab2 for Ab1 was 4-120-fold greater than Ab2 for homologous Ab1. Affinity-purified Ab2 did not block the binding of affinity-purified Ab1 to its HIV-1gp120 epitopes on immunoblot, indicating the absence of "internal image" antiidiotype. Both Ab1 and Ab2 are precipitable from sera with polyethylene glycol (PEG) and present in a macromolecular complex that is excluded by gel filtration on G200 and contains IgG, IgM, C3, and the anti-F(ab')2 antiidiotype-like complex. PEG-precipitable complexes bind to platelets in a saturation-dependent manner. Neither affinity-purified Ab1 nor Ab2 binds to platelets. However, the combination of Ab1 and Ab2 (preincubated for 2 h at 22 degrees C) binds to platelets in a saturation-dependent manner at an optimum ratio range of 10-20:1. Ab2 reactivity correlates with serum PEG-precipitable immune complex level (r = 0.91; P less than 0.001) and with thrombocytopenia (r = 0.89; P less than 0.001). We suggest that the anti-HIV-1gp120 antiidiotype-like complex contributes to the markedly elevated platelet Ig and C3 level of HIV-1-ITP patients and propose that this may contribute to their thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737832      PMCID: PMC442860          DOI: 10.1172/JCI115593

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Expression of CD4 by human megakaryocytes.

Authors:  R S Basch; Y H Kouri; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  The effect of azidothymidine on HIV-related thrombocytopenia.

Authors:  K B Hymes; J B Greene; S Karpatkin
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

3.  Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).

Authors:  O D Ratnoff; J E Menitove; R H Aster; M M Lederman
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

4.  On the mechanism of thrombocytopenic purpura in sexually active homosexual men.

Authors:  C M Walsh; M A Nardi; S Karpatkin
Journal:  N Engl J Med       Date:  1984-09-06       Impact factor: 91.245

5.  Autoimmune thrombocytopenic purpura in homosexual men.

Authors:  L Morris; A Distenfeld; E Amorosi; S Karpatkin
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

6.  Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection.

Authors:  J van der Lelie; J M Lange; J J Vos; C M van Dalen; S A Danner; A E von dem Borne
Journal:  Br J Haematol       Date:  1987-09       Impact factor: 6.998

7.  Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome.

Authors:  C C Stella; A Ganser; D Hoelzer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

8.  Survival of rabbit platelets exposed to immune complexes.

Authors:  A Parbtani; R L Kinlough-Rathbone; A Chahil; M Richardson; J F Mustard
Journal:  Exp Mol Pathol       Date:  1990-02       Impact factor: 3.362

9.  Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia.

Authors:  S Karpatkin; M A Nardi
Journal:  J Lab Clin Med       Date:  1988-04

10.  Target platelet antigen in homosexual men with immune thrombocytopenia.

Authors:  R B Stricker; D I Abrams; L Corash; M A Shuman
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

View more
  8 in total

Review 1.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

2.  GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia.

Authors:  M A Nardi; L X Liu; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

Review 4.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

5.  Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients.

Authors:  Iván Palomo; Marcelo Alarcón; Cecilia Sepulveda; Jaime Pereira; Ricardo Espinola; Silvia Pierangeli
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

Review 6.  Kaleidoscope of autoimmune diseases in HIV infection.

Authors:  Justyna Roszkiewicz; Elzbieta Smolewska
Journal:  Rheumatol Int       Date:  2016-08-20       Impact factor: 3.580

Review 7.  Pathobiology of secondary immune thrombocytopenia.

Authors:  Douglas B Cines; Howard Liebman; Roberto Stasi
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

8.  Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection.

Authors:  Olive Obienu; Sylvester Nwokediuko
Journal:  Hepat Med       Date:  2011-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.